drugset
drugset / Trial / NCT04388501

A Study Evaluating Drug Drug Interaction Between Milvexian and Atorvastatin in Healthy Participants

NCT04388501 ↗

Phase 1 Completed 23 enrolled Janssen Pharmaceutica N.V., Belgium
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to evaluate the potential pharmacokinetics (PK) interaction between milvexian and atorvastatin (and its metabolites) in healthy participants at steady state.

Timeline

Start
2021-06-07
Primary completion
2021-10-25
Completion
2021-10-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule — Oral
Subject Milvexian Small molecule — Oral

Indications

No indication recorded.